RecruitingNCT06354010
Cross-sectional and Prospective Study to Characterize Early-onset Presbycusis
Sponsor
Sensorion
Enrollment
100 participants
Start Date
Jun 14, 2024
Study Type
OBSERVATIONAL
Conditions
Summary
The purpose of this study is to characterize and assess the evolution of hearing impairment of patients with adulthood-onset bilateral sensorineural hearing loss carrying mutations on GJB2 gene.
Eligibility
Min Age: 30 YearsMax Age: 55 Years
Inclusion Criteria3
- Female or Male patients ≥30 and ≤55 years old
- Bilateral hearing loss first noticed after the age of 16 years old
- Documented genotyping results showing mutations in GJB2 gene.
Exclusion Criteria2
- Deafness with a known, non-genetic cause
- To the opinion of the investigator, unable and/or unwilling to comply with all the protocol requirements and/or study procedures
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
GENETICGenotyping
Genotyping to determine if patients present mutations to the gene GJB2.
OTHERAudiological assessments
Audiological assessments
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06354010
Related Trials
Speech Perception of a Tonotopy-based Fitting for Cochlear Implant Recipients for 6 Months With Conventional Setting
NCT067232621 location
Comparison of Speech Understanding Between Tonotopy-based Fitting and Setting Based on Evolutionary Algorithms
NCT067371851 location
Natural History in Children up to 16 Years With Mild to Profound Hearing Loss Due to Mutations in GJB2 / OTOF Genes
NCT054028131 location
Otoferlin Gene-mediated Hearing Loss Natural History Study
NCT0557207310 locations
Gene Therapy Trial for Otoferlin Gene-mediated Hearing Loss
NCT058219599 locations